Fundraising Fox

Oxford Medical Products

Oxford, GB · Founded 2017 · 26 employees on LinkedIn · 2 known investors

Oxford Medical Products develops medical devices, drawing on a team of biotech entrepreneurs, material scientists, polymer chemists and medical device engineers.

Also known as OMP

Investors · 2

Company profile

researched Aug 2026

Oxford Medical Products (OMP) is a medical device company that has developed a proprietary gastroretentive hydrogel platform intended to support two therapeutic applications: weight management and drug delivery. The platform is delivered as an orally administered hydrogel pill that swells rapidly in the stomach — reaching the size of a large marshmallow in under 30 minutes — and remains in the stomach for a pre-determined period before breaking down and being excreted naturally. The company states the system is tuneable, with formulations able to provide a range of one to seven days of gastroretention, and describes it as the first hydrogel technology of its kind to achieve multiday gastroretention.

Two product pathways are built on the platform. Sirona is a non-pharmacological treatment designed to help people manage overweight and obesity. OMP GEL GRDDS is a gastroretentive drug delivery system for controlled, long-term gastric delivery of small molecules and biologics. The company also identifies nutraceutical delivery and biosensors as further potential applications of the platform.

Full profile — technology, go-to-market

Technology

The core technology is a proprietary gastroretentive hydrogel formulated into a swallowable pill. After ingestion the pill swells in the stomach within 30 minutes to approximately the size of a large marshmallow, is retained in the stomach for a pre-set duration, and then degrades and passes out of the body naturally. The formulation is described as tuneable across a 1-7 day gastroretention range, supporting both a non-pharmacological weight-management device (Sirona) and a drug delivery system (OMP GEL GRDDS) for small molecules and biologics.

Go-to-market

Adults seeking to manage overweight and obesity, addressed through the Sirona weight-management product, and pharmaceutical developers of small molecules and biologics that require controlled, long-term gastroretentive delivery via the OMP GEL GRDDS system.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Gastroretention duration rangeJan 20251-7 days (tuneable formulations)
HeadcountAug 202626
Time for pill to swell in stomachJan 2025under 30 minutes

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Legal entities · 1

corporate structure
Oxford Medical ProductsNo. 10530319 · inc. Dec 2016 · active

Companies House · registry record

View on Companies House ↗
Registered name
OXFORD MEDICAL PRODUCTS LIMITED
Company number
10530319
Status
Active
Company type
Private limited company
Incorporated
17 Dec 2016
Registered office
Unit 3, The Gateway, Windrush Park Road, Witney, Oxfordshire, OX29 7EY
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Previous names
SATIE8 LIMITED (20172019)JAMCOWP01 LIMITED (20162017)
Accounts
last made up to 30 Sept 2025 · next due 30 Jun 2027
Confirmation statement
last made up to 7 Feb 2026 · next due 21 Feb 2027

Current officers · 4

  • Camilla Easter director, appointed 5 Dec 2019
  • Nicholas Huw Edwards director, appointed 3 Jan 2017
  • Craig Andrew Marshall director, appointed 1 Jul 2026
  • Robert Vee-Lin Thong director, appointed 2 Feb 2022

Source: Companies House public register · retrieved 5 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Oxford Medical Products do?
Oxford-based developer of a gastroretentive hydrogel platform used for weight management and oral drug delivery.
Who are Oxford Medical Products's investors?
Oxford Medical Products's investors include Oxford Investment Opportunity Network (OION), Ada Ventures.
Where is Oxford Medical Products headquartered?
Oxford Medical Products is headquartered in Oxford, GB.